Skip to main content
Figure 6 | Breast Cancer Research

Figure 6

From: Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells

Figure 6

FASN activity in breast cancer cells treated with C75. FASN activity was measured in SKBR3 (A) and BT474 (B) cells treated with: 1) no agent (control); 2) 50 ng/mL HRG; 3) 10 μM C75 or 4) 50 ng/mL HRG plus 10 μM C75. A simple t-test was used to assess the differences in FASN activity between any two experimental conditions. *, statistically significant compared with FASN activity in control cells; #, statistically significant compared with FASN activity in cells treated with HRG; P < 0.05 was considered statistically significant.

Back to article page